Comparison of Treatment Failure Criteria in HIV-Infected Children in Uganda
NCT04489953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133
Last updated 2020-07-28
Summary
The main goal was to compare clinical and immunological versus clinical, immunological plus viral load criteria for switching to second-line ART by comparing 48 week treatment outcomes, including survival rates, viral suppression, failure to thrive, and AIDS-defining illnesses for treatment experienced children randomized to two switching criteria.
Conditions
Interventions
- OTHER
-
Viral Load
For the Clinical and Immunologic criteria, viral load was done retrospectively on stored plasma samples. Whereas for the Clinical, Immunologic and Virologic criteria, viral load was done in real-time
Sponsors & Collaborators
-
MU-JHU CARE
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-01
- Primary Completion
- 2017-01-16
- Completion
- 2017-01-16
More Related Trials
-
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
NCT02028676 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV
NCT01529125 ·Status: COMPLETED
-
Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa
NCT03848728 ·Status: COMPLETED ·Phase: NA
-
Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection
NCT03800407 ·Status: COMPLETED
-
Early HIV Therapy in Patients With High CD4 Cell Counts
NCT01479634 ·Status: COMPLETED ·Phase: NA
-
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
NCT00663234 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Comparison of Facility and Home-based ART Delivery Systems in Uganda
NCT00144365 ·Status: COMPLETED ·Phase: PHASE3
-
Examining HIV Treatment Adherence During Early Disease
NCT02419066 ·Status: COMPLETED
-
Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy
NCT01825031 ·Status: COMPLETED ·Phase: PHASE3
-
Relationship Between HIV-1 Subtype and ARV Response
NCT00585793 ·Status: COMPLETED
-
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
NCT00931346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
NCT00557245 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)
NCT00868257 ·Status: COMPLETED
-
Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda
NCT00342160 ·Status: COMPLETED
-
Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
NCT00674921 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Intensive Adherence Counselling Among People Living With HIV/AIDS With Low-level Viraemia in Uganda.
NCT05514418 ·Status: UNKNOWN ·Phase: NA
-
HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
NCT06126913 ·Status: RECRUITING ·Phase: NA
-
A Study of Megestrol Acetate in HIV-Infected Children
NCT00002182 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.
NCT05372510 ·Status: UNKNOWN
-
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
NCT05085171 ·Status: RECRUITING ·Phase: PHASE3
-
Cryptococcal Optimal ART Timing Trial
NCT01075152 ·Status: COMPLETED ·Phase: PHASE4
-
Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa
NCT06133686 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
NCT00620438 ·Status: UNKNOWN ·Phase: PHASE4
-
Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
NCT00617643 ·Status: COMPLETED ·Phase: PHASE4